By Suling Liu, Hasan Korkaya, and Max S. Wicha | April 1, 2012 Inthe 30-year battle waged since the initiation of the war on cancer, there have been substantial victories, with cures for childhood malignancies among the most important. Our ever-expanding understanding of cellular and molecular biology has provided substantial insights into the molecular underpinnings of the spectrum of diseases we call cancer.
As the basketball frenzy that accompanies March Madness draws to the fever pitch of the Final Four, it brings to mind that basketball is a high contact sport. A quick peek at the NBA injured list reveals a catalog of breaks and tears that affect tendons, ligaments and bones.
LOS ANGELES–(BUSINESS WIRE)– ImmunoCellular Therapeutics, Ltd. (ImmunoCellular or the Company) (OTCBB: IMUC.OB – News), a biotechnology company focused on the development of novel immune-based cancer therapies, announced today that the Company will deliver a presentation on the identification and characterization of immunogenic epitopes from CD133 and their potential for use to immunologically target cancer stem cells (CSCs) at the Annual Meeting of the American Association for Cancer Research, which will be held from March 31 to April 4, 2012 at McCormick Place in Chicago, Illinois
SUNRISE, Fla., March 22, 2012 (GLOBE NEWSWIRE) — Bioheart, Inc. (OTCBB:BHRT.OB – News), a company focused on developing stem cell therapies for heart disease, previously announced that they entered into an agreement with Stemlogix, LLC, a veterinary regenerative medicine company, to provide additional cellular products and services to the veterinary market. Under this agreement, the companies are offering stem cell banking for veterinary patients (pets)
FORT WASHINGTON, Pa.–(BUSINESS WIRE)– The National Comprehensive Cancer Network (NCCN) has issued its first ever NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Acute Lymphoblastic Leukemia (ALL). The new guidelines were presented by the co-chairs of the NCCN ALL Panel, Joseph C.
Newswise PHILADELPHIA Researchers at the Kimmel Cancer Center at Jefferson have demonstrated for the first time that the metabolic biomarker MCT4 directly links clinical outcomes with a new model of tumor metabolism that has patients feeding their cancer cells. Their findings were published online March 15 in Cell Cycle.
Timothy Brown, now HIV-negative, embodies hope at conference If there was one word to describe the focus of the second annual HIV/AIDS Conference Saturday at the Annenberg Center for Health Sciences in Rancho Mirage, it would be hope. A link to this page will be included in your message
INCLINE VILLAGE, Nev. Aging is a natural, necessary part of life.
NEEDHAM, Mass.–(BUSINESS WIRE)– Celldex Therapeutics, Inc.
By Monica Heger Researchers at BGI have published two papers in Cell outlining a single-cell exome sequencing technique that they demonstrated on cell lines, a previously sequenced genome, and cancer patient samples. The papers show that single-cell analysis can provide a much finer-grained genetic characterization of heterogeneous tissues than bulk tissue sequencing and also point toward the use of the method in areas beyond cancer, such as stem cell research and preimplantation genetic diagnosis, according to the BGI researchers. Moving forward, the team plans to improve the technique and use it to analyze single cells from different cancer types to study “metastasis, recurrence, and [tumors] before and after therapy,” Luting Song, project manager at BGI and a co-author on the papers, told In Sequence in an e-mail.
Public release date: 2-Mar-2012 [ | E-mail | Share ] Contact: Jia Liu liujia@genomics.cn BGI Shenzhen March 2, 2012, Shenzhen China BGI, the world’s largest genomics organization, developed single-cell genome sequencing technology and published two research papers for cancer single-cell sequencing in the research journal Cell. In the papers, which were published today in the same issue of Cell, BGI researchers applied their new single-cell sequencing (SCS) method to identify the genetic characteristics of essential thrombocythemia (ET, a kind of blood neoplasm) and clear cell renal cell carcinoma (ccRCC, a typical kidney cancer), and demonstrated that single cell analyses of highly heterogeneous tissues provide much clearer intratumoral genetic pictures and developmental history than previous bulk tissue sequencing. The availability of BGI’s SCS method opens new ways for the genetic study of tumors at single nucleotide resolution, especially for those where it is difficult to identify key mutations by previous bulk tissue sequencing.
By Andrew Winner There are those who say theres a use for every little thing in this world, no matter how vile or off-putting.
ScienceDaily (Feb. 26, 2012) — For the first time, Massachusetts General Hospital (MGH) researchers have isolated egg-producing stem cells from the ovaries of reproductive age women and shown these cells can produce what appear to be normal egg cells or oocytes. In the March issue of Nature Medicine, the team from the Vincent Center for Reproductive Biology at MGH reports the latest follow-up study to their now-landmark 2004 Nature paper that first suggested female mammals continue producing egg cells into adulthood
VILLA GUARDIA, Italy, Feb.
Public release date: 26-Feb-2012 [ | E-mail | Share ] Contact: Sue McGreevey smcgreevey@partners.org 617-724-2764 Massachusetts General Hospital For the first time, Massachusetts General Hospital (MGH) researchers have isolated egg-producing stem cells from the ovaries of reproductive age women and shown these cells can produce what appear to be normal egg cells or oocytes.
BELGRADE, Mont., Feb. 24, 2012 /PRNewswire/ — Bacterin International Holdings, Inc
Over 300 high school students from around the state invaded Arizona State University Polytechnic campus Thursday for the Making Your Future conference to advance student learning and understanding in the areas of science, technology, engineering and math.
28-12-2010 13:43 Ross Hauser, MD is a full time Prolotherapy physician in Chicago land. He offers comprehensive Prolotherapy, including Bone Marrow Prolotherapy, also known as Stem Cell Prolotherapy. In this video, he discusses the stem cell treatment and how the bone marrow is obtained and administered.
VILLA GUARDIA, Italy, Feb. 21, 2012 (GLOBE NEWSWIRE) — Gentium S.p.A
An important new study by a team of scientists at RhinoCyte™ Inc., Louisville, Ky., details promising results on the effectiveness of olfactory (nasal) stem cells in repairing spinal cord damage resulting from the most common cause of these injuries — contusions (bruising) due to major trauma such as is seen in auto accidents, falls or combat. This could have major implication for the estimated 5 million people worldwide affected by spinal cord injuries – 1.275 million of them in the United States alone, where the cost of treatment exceeds $40.5 billion each year.